Masanori Atsukawa

机构：Nippon Medical School Hospital, Nippon Medical School · ORCID：0000-0003-3374-7111

发表论文 358 篇 · 总被引 5922 次 · h-index 42

代表论文

• Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study (2025 · Liver International · 被引 8)
• Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
• Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis (2025 · Hepatology · 被引 6)
• Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial (2025 · Hepatology Communications · 被引 4)
• Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab (2025 · Hepatology Research · 被引 4)
• Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus (2025 · Hepatology Research · 被引 3)